Reykjavik, Iceland

Anna Helgadottir

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Reykjavik, IS (2009 - 2014)
  • Reykjavík, IS (2012 - 2017)

Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Innovator Spotlight: Anna Helgadottir

Introduction: Anna Helgadottir, an accomplished inventor based in Reykjavik, Iceland, is recognized for her significant contributions to the field of genetics and cardiovascular health. With a portfolio of five patents, her work has advanced the understanding of genetic susceptibility to various cardiovascular conditions.

Latest Patents: Among her latest inventions are two groundbreaking patents. The first patent focuses on genetic susceptibility variants associated with cardiovascular disease. It includes methods for diagnosing susceptibility to conditions such as coronary artery disease, abdominal aorta aneurysm, intracranial aneurysm restenosis, and peripheral arterial disease. This invention also features kits containing reagents for assessing specific polymorphic markers linked to cardiovascular diseases, facilitating tailored therapeutic approaches. The second patent centers on genetic markers for risk management related to atrial fibrillation, atrial flutter, and stroke. This invention outlines procedures for determining susceptibility to these cardiac arrhythmias through the analysis of specific genetic markers and incorporates diagnostic methods alongside useful kits.

Career Highlights: Throughout her career, Anna has made significant strides in genetics and cardiovascular research. Her roles in reputable companies such as Decode Genetics Ehf and Decode Genetics Chf have positioned her at the forefront of innovative medical advancements.

Collaborations: Anna Helgadottir has collaborated with notable professionals in the field, including Hákon Hákonarson and Jeffrey R. Gulcher. These partnerships have enhanced her research and development efforts, driving impactful innovations in genetic diagnostics.

Conclusion: Anna Helgadottir stands out as a pioneering inventor whose work addresses critical aspects of cardiovascular health through genetic insights. Her patents reflect her commitment to advancing medical science and improving patient outcomes, marking her as a key figure in the world of innovations and inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…